Granahan Investment Management, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1026710 WALTHAM, MA

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,809,527

+$2,521,612 QoQ

Shares Held

332,192

+41.0% QoQ

Ownership

0.286%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 90.7803318562759.ToString("F0")% Shared 0.ToString("F0")% None 9.21966814372411.ToString("F0")%

Healthcare · as of Mar 31, 2026

Granahan Investment Management, LLC holds $141,409,593 across 24 Biotechnology names. VKTX ranks #2 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STOK	Stoke Therapeutics, Inc.	335,586	$10,926,680
2	VKTX	Viking Therapeutics, Inc. This page	332,192	$10,809,527
3	CELC	Celcuity Inc.	88,833	$10,139,398
4	SRRK	Scholar Rock Holding Corp	156,314	$7,684,396
5	BBIO	BridgeBio Pharma, Inc.	102,911	$7,642,170
6	SNDX	Syndax Pharmaceuticals Inc	306,321	$7,155,658
7	RYTM	Rhythm Pharmaceuticals, Inc.	77,709	$6,758,351
8	IMNM	Immunome Inc.	307,021	$6,714,549

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,809,527	332,192	+41.0%	Shares	Sole	2026-05-15
2025-12-31	$8,287,915	235,586	+24.3%	Shares	Sole	2026-02-17
2025-09-30	$4,980,822	189,529	-37.9%	Shares	Sole	2025-11-14
2025-06-30	$8,084,911	305,091	-17.1%	Shares	Sole	2025-08-14
2025-03-31	$8,886,258	367,961	+20.4%	Shares	Sole	2025-05-15
2024-12-31	$12,296,780	305,586	-6.1%	Shares	Sole	2025-02-14
2024-09-30	$20,593,919	325,287	-14.1%	Shares	Sole	2024-11-14
2024-06-30	$20,074,780	378,698	+18.8%	Shares	Sole	2024-08-14
2024-03-31	$26,149,226	318,893	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.